Australia markets closed

TFF Pharmaceuticals, Inc. (TFFP)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.89000.0000 (0.00%)
At close: 04:00PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
21,281
12,061
18,496
21,301
10,682
Selling general and administrative
13,427
10,567
13,796
10,574
8,012
Total operating expenses
34,512
21,895
31,797
31,787
18,694
Operating income or loss
-34,512
-21,895
-31,797
-31,787
-18,694
Total other income/expenses net
-
385.243
-
696.714
-
Income before tax
-34,447
-21,243
-31,770
-31,039
-18,567
Income from continuing operations
-34,447
-21,243
-31,770
-31,039
-18,567
Net income
-34,447
-21,243
-31,770
-31,039
-18,567
Net income available to common shareholders
-34,447
-21,243
-31,770
-31,039
-18,567
Basic EPS
-12.75
-11.85
-26.49
-31.25
-22.75
Diluted EPS
-12.75
-11.85
-26.49
-31.25
-22.75
Basic average shares
1,637
1,793
1,199
992.838
817.006
Diluted average shares
1,637
1,793
1,199
992.838
817.006